Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vivos Therapeutics (VVOS) Cash & Equivalents (2019 - 2026)

Updated

Vivos Therapeutics' Cash & Equivalents was $1.8 million in Q2 2026, down 59.1% from $4.4 million a year earlier and down 14.7% from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Cash & Equivalents (2019 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Vivos Therapeutics came in at $2.03 million, down 67.6% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of -35.5% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $6.26 million in FY2024 (+281.0%), $1.64 million in FY2023 (-53.3%), $3.52 million in FY2022 (-85.4%) and $24.03 million in FY2021 (+32.0%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q4 2023.
  • Compared with a year earlier, Cash & Equivalents has declined for six straight quarters, with growth averaging 72.3% over the last eight quarters.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q3 2024 (growth of 531.1%); the worst was Q4 2022 (a decline of 85.4%).
  • Per Business Quant data, VVOS's Cash & Equivalents in the three quarters before Q2 2026 was $2.11 million (Q1 2026), $2.03 million (Q4 2025) and $3.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 4.06 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 5.10 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 4.35 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 2.76 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 1.69 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 3.39 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 539.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 2.91 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 708.00 Mn
10 Vivos Therapeutics 2.18 Mn -7.03 Mn 2.95 Mn 1.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.80 Mn
Mar 31, 2026 2.11 Mn
Dec 31, 2025 2.03 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 2.34 Mn
Dec 31, 2024 6.26 Mn
Sep 30, 2024 6.31 Mn
Jun 30, 2024 6.90 Mn
Mar 31, 2024 2.61 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 3.94 Mn
Mar 31, 2023 7.05 Mn
Dec 31, 2022 3.52 Mn
Sep 30, 2022 6.72 Mn
Jun 30, 2022 12.70 Mn
Mar 31, 2022 17.83 Mn
Dec 31, 2021 24.03 Mn
Sep 30, 2021 28.53 Mn
API Access

Vivos Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VVOS&period=max&api_key=YOUR_API_KEY